Alpha Teknova, Inc. (TKNO) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↓
4.07
↑+40% vs avg
5yr avg: 2.92
30Y Low1.3·High4.7
ROE
↓
-22.8%
↓+19% vs avg
5yr avg: -28.3%
30Y Low-39%·High11%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
TKNO Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Alpha Teknova, Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $281M | $203M | $390M | $119M | $158M | $574M | — | — |
| Enterprise Value | $290M | $212M | $417M | $121M | $158M | $498M | — | — |
| P/E Ratio → | -16.38 | — | — | — | — | — | — | — |
| P/S Ratio | 6.93 | 5.02 | 10.34 | 3.24 | 3.82 | 15.55 | — | — |
| P/B Ratio | 4.07 | 2.96 | 4.74 | 1.32 | 1.59 | 4.01 | — | — |
| P/FCF | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
TKNO EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 5.24 | 11.04 | 3.29 | 3.83 | 13.50 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — |
TKNO Profitability
Margins and return-on-capital ratios measuring operating efficiency
Alpha Teknova, Inc. earns an operating margin of -41.9%. Operating margins have expanded from -96.9% to -41.9% over the past 3 years, signaling improving operational efficiency. A negative ROE of -22.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 33.2% | 33.2% | 19.2% | 28.1% | 42.2% | 47.8% | 56.7% | 42.7% |
| Operating Margin | -41.9% | -41.9% | -69.3% | -96.9% | -119.9% | -32.5% | 14.9% | -9.2% |
| Net Profit Margin | -42.6% | -42.6% | -70.9% | -100.3% | -114.6% | -26.6% | 11.4% | -6.5% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -22.8% | -22.8% | -31.0% | -38.7% | -39.1% | -10.0% | 10.9% | -10.1% |
| ROA | -15.5% | -15.5% | -21.6% | -26.2% | -29.8% | -8.5% | 5.9% | -2.2% |
| ROIC | -13.6% | -13.6% | -19.5% | -27.8% | -44.5% | -15.4% | 12.1% | -15.8% |
| ROCE | -16.7% | -16.7% | -23.0% | -27.2% | -33.1% | -11.0% | 8.3% | -3.5% |
TKNO Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $9M ($15M total debt minus $6M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.22 | 0.22 | 0.37 | 0.34 | 0.42 | 0.08 | — | 0.00 |
| Debt / EBITDA | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.13 | 0.32 | 0.02 | 0.00 | -0.53 | -0.06 | -0.32 |
| Net Debt / EBITDA | — | — | — | — | — | — | -0.49 | — |
| Debt / FCF | — | — | — | — | — | — | — | — |
| Interest Coverage | -23.23 | -23.23 | -38.06 | -37.45 | — | -20.39 | — | — |
TKNO Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Alpha Teknova, Inc.'s current ratio of 4.58x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 3.64x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 5.14x to 4.58x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.58 | 4.58 | 3.82 | 5.14 | 5.62 | 13.07 | 4.14 | 2.76 |
| Quick Ratio | 3.64 | 3.64 | 3.21 | 3.84 | 4.50 | 12.37 | 3.24 | 2.30 |
| Cash Ratio | 0.78 | 0.78 | 2.71 | 3.21 | 3.88 | 11.30 | 1.29 | 1.73 |
| Asset Turnover | — | 0.39 | 0.32 | 0.29 | 0.27 | 0.22 | 0.50 | 0.34 |
| Inventory Turnover | 3.84 | 3.84 | 4.49 | 2.28 | 1.96 | 3.57 | 3.78 | 4.49 |
| Days Sales Outstanding | — | 41.60 | 41.70 | 39.28 | 37.74 | 57.92 | 76.61 | 54.24 |
TKNO Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Alpha Teknova, Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $53M | $47M | $32M | $28M | $28M | $4M | $4M |
Peer Comparison
Compare TKNO with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 TKNOYou | $281M | -16.4 | — | — | 33.2% | -41.9% | -22.8% | -13.6% | — |
 AZTA | $1B | -19.1 | 18.1 | 28.0 | 45.5% | -1.9% | -3.2% | -0.5% | 2.2 |
 BRKR | $9B | -381.5 | 22.9 | 201.2 | 45.9% | 6.9% | -0.4% | 4.4% | 4.5 |
 NTRA | $33B | -152.2 | — | 303.7 | 64.8% | -13.4% | -14.3% | -36.1% | — |
 PACB | $435M | -0.8 | — | — | 31.7% | -348.5% | -213.5% | -45.8% | — |
 FLGT | $535M | -9.1 | — | — | 40.6% | -28.2% | -5.4% | -6.4% | — |
 CRL | $9B | -63.6 | 12.9 | 17.2 | 30.5% | 12.6% | -4.3% | 6.3% | 3.4 |
 MEDP | $13B | 30.1 | 22.9 | 19.3 | 30.1% | 21.1% | 70.2% | 154.9% | 0.4 |
 ICLR | $11B | 50.3 | 10.1 | 13.0 | 26.4% | 12.3% | 2.5% | 6.2% | 2.5 |
 RVTY | $11B | 48.1 | 20.9 | 22.0 | 53.1% | 12.5% | 3.2% | 2.7% | 5.3 |
 QGEN | $8B | 18.1 | 11.8 | 16.8 | 61.8% | 24.9% | 11.6% | 8.6% | 2.3 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
TKNO — Frequently Asked Questions
Quick answers to the most common questions about buying TKNO stock.
What is Alpha Teknova, Inc.'s P/E ratio?
Alpha Teknova, Inc.'s current P/E ratio is -16.4x. This places it at the 50th percentile of its historical range.
What is Alpha Teknova, Inc.'s ROE?
Alpha Teknova, Inc.'s return on equity (ROE) is -22.8%. The historical average is -20.1%.
Is TKNO stock overvalued?
Based on historical data, Alpha Teknova, Inc. is trading at a P/E of -16.4x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Alpha Teknova, Inc.'s profit margins?
Alpha Teknova, Inc. has 33.2% gross margin and -41.9% operating margin.